S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study
S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study have?
S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study has 3 citations in the OpenAlex counts ScholarIQ stores.
When was S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study published?
S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study has 2024 year in the ScholarIQ index.
What is the open-access status of S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study?
S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study has closed oa status in the ScholarIQ index.
What is the DOI of S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study?
The DOI for S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study is on the source record.
What is the OpenAlex record for S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study?
The OpenAlex for S1467 Risk of Inflammatory Bowel Disease Complications in Obese Inflammatory Bowel Disease Patients on GLP-1 Therapy: A Large Multicenter Cohort Study is on the source record.